Axis Bank Limited Appointment of Whole Time Director (4388R)

TIDMAXB TIDMAXBA

RNS Number : 4388R

Axis Bank Limited

26 October 2023

AXIS/CO/CS/390/2023-24

October 26, 2023

D e ar Sir(s),

SUB.: APPOINTMENT OF WHOLE-TIME DIRECTOR

REF.: DISCLOSURE UNDER REGULATION 30 OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

This is to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Axis Bank Limited ("the Bank") at its meeting held today, i.e. October 26, 2023, has approved the appointment of Munish Sharda (DIN: 06796060) as a Whole-time Director, designated as "Executive Director" of the Bank (including his terms and conditions and remuneration), effective from (i) November 1, 2023; or (ii) the date of approval of his appointment by Reserve Bank of India ("RBI"), whichever is later.

The above appointment is for a period of 3 (three) years from the effective date of his appointment and is subject to approval of the shareholders of the Bank and RBI. Munish Sharda would be liable to retire by rotation.

The brief profile of Munish Sharda is attached herewith as Annexure A.

Please note that Munish Sharda is not related to any other Director or Key Managerial Personnel of the Bank. He has not been debarred from holding the office of a Director by virtue of any order passed by SEBI or any other regulatory/ statutory authority.

Please note that the Board Meeting commenced at 9.30 am and concluded at 4.55 p.m.

http://www.rns-pdf.londonstockexchange.com/rns/4388R_1-2023-10-26.pdf

You are requested to take note of the above and arrange to bring it to the notice of all concerned.

Thanking You.

Y ours S incerely,

For Axis Bank Limited

Sandeep Poddar

Company Secretary

CC: London Stock Exchange

Singapore Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAPPGWAUUPWGGQ

(END) Dow Jones Newswires

October 26, 2023 07:56 ET (11:56 GMT)